1 October 2023
Foley Represents Bioluminescence Ventures as Lead Investor in ReCode Therapeutics Series B Funding Extension
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Louis Lehot Lead | Foley & Lardner LLP | Partner | Venture & Growth Capital | Not stated |
| Lyman Thai | Foley & Lardner LLP | Partner | Not stated | Not stated |
| Antoinette Konski | Foley & Lardner LLP | Partner | Not stated | Not stated |
| Jeff Lomprey | Foley & Lardner LLP | Partner | Not stated | Not stated |
| Rishi Sodhi | Foley & Lardner LLP | Partner | Not stated | Not stated |
| Andy Rawlins | Foley & Lardner LLP | Partner | Not stated | Not stated |
| Ashley Lee | Foley & Lardner LLP | Associate | Not stated | Not stated |
| Wesley Choi | Foley & Lardner LLP | Associate | Not stated | Not stated |
| Cayman Weimer | Foley & Lardner LLP | Associate | Not stated | Not stated |
6 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 50m ($50 million)
- What the figure measures
- Issue size
- Client
- Bioluminescence VenturesInvestor
- Counterparties
- ReCode Therapeutics (Issuer)